Interventional Cardiology Devices Market worth $25.5 billion by 2027
The report "Interventional Cardiology Devices Market by type (Stents, Structural Heart, Catheters, Plaque Modification (Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath, IVUS)) - Global Forecast to 2027" The global interventional cardiology devices market size is projected to reach USD 25.5 billion by 2027 from USD 17.5 billion in 2022, at a CAGR of 7.7%. Market is driven by factors such as growing prevalence of coronary artery disease and increasing consumption of tobacco. Emerging economies growth potential is anticipated to propel market growth opportunities. However, low affordability and inaccessibility of cardiac surgeries in developing countries is anticipated to hinder market development.
Browse 179 market data Tables and 38 Figures spread through 196 Pages and in-depth TOC on "Interventional Cardiology Devices Market by type (Stents, Structural Heart, Catheters, Plaque Modification (Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath, IVUS)) - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html
The old/normal balloons segment accounted for the largest share of the angioplasty balloons market in 2019.
Based on type, the angioplasty balloons market is segmented into old/normal balloons, cutting and scoring balloons, and drug-eluting balloons. In 2019, the old/normal balloons segment accounted for the largest share of the angioplasty balloons market. The large share of this segment can be attributed to a increasing its use in impating the stents and structural heart devices; and increasing prevalence of vaulvuloplasty.
Thrombectomy devices segment accounted for the largest share of the plaque modification devices market in 2019.
Based on type, the plaque modification devices market is segmented into atherectomy devices and thrombectomy devices. In 2019, the thrombectomy devices segment accounted for the largest share of the plaque modification devices market. Growth in this market segment can largely be attributed to the increasing incidence of blood clots and atrial embolisms across the globe.
Angioplasty stents in product segment to witness the highest growth rate during the forecast period.
Based on the Product, the interventional cardiology devices is classified into angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, and other interventional cardiology devices. The angioplasty stents segment is expected to dominate because of technological advancements and companies developing innovative drug-eluting stents to enhance the strength and flexibility of these devices.
US dominates the North American Interventional cardiology devices Market.
Based on the North America region, the Interventional cardiology devices Market is divided into US and Canada. US is expected to dominate the Interventional cardiology devices Market. The availability of reimbursements for interventional cardiology surgeries and the large base of major device manufacturers in the country are the key factor driving market growth in the US.
Some of the major players in the interventional cardiology devices market include Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), Edward Lifescinces Corporation (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Interventional Cardiology Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
